Navigation Links
Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
Date:4/1/2008

nd other body tissues. Patients suffering from this disease fatigue easily, and become increasingly less capable of normal activity as they progress through the various stages of the disease. Current standard of care typically involves drug therapy and/or the implantation of a pacemaker and/or defibrillator device to regulate heart function.

ABOUT BIOHEART, INC.

Bioheart, Inc. is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its lead product candidate, MyoCell, is an innovative clinical cell therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from the patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company's pipeline includes multiple product candidates for the treatment of heart damage, including Bioheart Acute Cell Therapy, an autologous, adipose cell treatment for acute heart damage, and MyoCell SDF-1, a therapy utilizing autologous cells genetically modified to express additional growth factors.

Forward-Looking Statements:

Except for historical matters contained herein, statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Without limiting the generality of the foregoing, words such as "may", "will", "to", "plan", "expect", "believe", "anticipate", "intend", "could", "would", "estimate", or "continue" or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements.

Investors and others are cautioned that a variety of factors, including certain risks, may affect our business and cause actual results to differ materially from those set forth in the forward-looking statements. These risk factors inclu
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
2. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
3. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
4. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
5. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
6. Hope for Emphysema Sufferers: Clinical Trial That May Help Patients Breathe Easier Begins at Central DuPage Hospital
7. TAXUS(R) Stent Demonstrates Similar Outcomes in Diabetic Patients Compared to Non-diabetics in Pooled Analysis of TAXUS IV and V Trials
8. Major Deficiencies in Design; Funding of Clinical Trials Affects Future of Scientific Innovation
9. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
10. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
11. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... QC , Nov. 20, 2014 /CNW Telbec/ - ... to announce the following appointments: ... team in the newly created role of Chief Commercial ... BioPhotonic system using topical photoconverter gel for the treatment ... surgical and traumatic wounds, recently approved in ...
(Date:11/21/2014)... 20, 2014 Depomed, Inc. (NASDAQ: DEPO ) ... 26 th Annual Healthcare Conference in New York ... conference is scheduled for 8:00 am EST (5:00 am PST) on ... webcast can be accessed via the Investor Relations page of the ... will be archived for 30 days on the company,s website. ...
(Date:11/21/2014)... 2014   Wellcentive , the industry leader ... organizations, announced today being named one of the ... Award .  Sponsored by Intel, the world leader ... year, recognizes companies developing leading-edge technology and unique ... Wellcentive,s Mason Beard , ...
Breaking Medicine Technology:KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3
... Launches 1,000-Patient Lung Cancer Diversity Study, CHICAGO, June ... the leading cause of cancer death in,African-Americans, with ... deaths expected this year.(i) Equally devastating, lung,cancer is ... men and the,second leading cause of cancer death ...
... an overall CBR of 52% which compares ... CITY, QC, June 04, 2007 /PRNewswire-FirstCall/ - ... focused on,endocrine therapy and oncology, today announced ... outlining Phase 1 and,Phase 2 results for ...
Cached Medicine Technology:Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 2Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 3Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 4Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 5Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 6Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 7Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 8Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 9Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 10Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 11AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 2AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 3AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 4
(Date:11/21/2014)... OXNARD, CA (PRWEB) November 21, 2014 For ... worth the multiple office visits and months of recovery from ... mouth reconstruction – even at the cost of their youthful ... the Anacapa Dental Art Institute in Oxnard and Woodland Hills, ... teeth in one visit, even in instances where the patient’s ...
(Date:11/21/2014)... 21, 2014 Even with years of experience ... learn and room for growth, participating in two recent events ... Farm’s National Convention, a networking event with the leaders of ... bringing back the latest and greatest in insurance news and ... Kirk and his team (Stacy, Anthony, Reina and Jacob) as ...
(Date:11/21/2014)... Palm Beach, FL (PRWEB) November 21, 2014 ... report issued on June 11th, 2014, the ... Corporation can rupture when the airbag inflates. The force ... into metal shrapnel, and the metal shards may pierce ... within the vehicle’s cabin. , According to a ...
(Date:11/21/2014)... Maureen Salamon HealthDay ... -- Jobs requiring intellectually challenging tasks may help preserve ... study suggests. The researchers compared IQ scores ... people with their memory and reasoning scores around age ... stimulating jobs appeared to retain sharper thinking even years ...
(Date:11/21/2014)... -- While levels of testosterone and other reproductive hormones ... emotional health and quality of their relationships have a ... is the main sex hormone in men. But, women,s ... the researchers noted. The researchers analyzed data from ... long-term study of women,s health. They found that women ...
Breaking Medicine News(10 mins):Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 2Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 3Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 4Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 5Health News:Kirk Martin Insurance Agency Goes Local and National with State Farm 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 3Health News:Could Your Job Help Preserve Your Aging Brain? 2Health News:Could Your Job Help Preserve Your Aging Brain? 3Health News:Testosterone Plays Minor Role in Older Women's Sex Lives, Study Finds 2
... The holidays will be a little,brighter for children receiving ... to supermarket partners Ralphs and Food 4,Less. , ... announced today that they will be presenting a,$125,000 holiday ... in Southern California. The grants to the children,s hospitals ...
... AUGUSTA, Ga. The Robert W. Woodruff Foundation has ... College of Georgia School of Dentistry building. , "This ... Daniel W. Rahn. "This helps demonstrate to other foundations ... support. The gift is contingent upon groundbreaking for the ...
... KMB ) today announced the evolution of its market-leading ... first line of gender-specific adult absorbent underwear. The new ... body shapes of men and women - offering superior fit ... full and active life. , ...
... The first approval for an antibody generated from Medarex,s UltiMAb(R) ... PRINCETON, N.J., Dec. 15 Medarex, Inc. (Nasdaq: ... payment from its licensing partner, Centocor Inc., in connection with ... Genetic Therapies Directorate, to market STELARA ...
... who seek intimacy in relationships? It may be a ... in the Journal of Consumer Research , people,s ... In psychology, different relationship styles are known as "attachment ... (University of Pittsburgh), and Rohini Ahluwalia (University of Minnesota) ...
... people , , MONDAY, Dec. 15 (HealthDay News) -- Certain people ... discovery of six additional genetic variants tied to people with ... The study by an international consortium, published online Dec. ... that linked two other genetic variants to obesity. , ...
Cached Medicine News:Health News:Southern California Children's Hospitals to Receive $125,000 Holiday Gift From Ralphs and Food 4 Less 2Health News:Woodruff Foundation pledges $3 million toward MCG dental building 2Health News:Kimberly-Clark Introduces New Depend Underwear for Men & Women; Unveils Brand's First Gender-Specific Adult Absorbent Underwear 2Health News:Kimberly-Clark Introduces New Depend Underwear for Men & Women; Unveils Brand's First Gender-Specific Adult Absorbent Underwear 3Health News:Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis 2Health News:Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis 3Health News:Filling in the gaps: Personality types lead people to choose certain brands 2Health News:Genetic Variants Tied to Obesity 2
... MedPoint™, a Medication Administration Control System, ... assurance that they are administering the ... used with a bar coded patient ... extends the benefits of the hospital's ...
... MediMAR™ is the newest Mediware ... medication administration record. MediMAR produces a ... patient's medication profile, including clinician orders, ... to medication administration or alerts that ...
... When it comes to medication administration, ... afford to make. The solution is the ... a highly-scalable bar-coded medication administration system, suitable ... also be used stand-alone, networked, or as ...
... Outlook® Safety Infusion System is designed to ... drug, and the right dose. Available in ... Outlook® Safety Infusion System allows hospitals to ... meet their needs. DoseGuard™ dose limit technology ...
Medicine Products: